Twist Bioscience (FRA:0ME) ROE % Adjusted to Book Value : -8.98% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Twist Bioscience ROE % Adjusted to Book Value?

Twist Bioscience's ROE % for the quarter that ended in Mar. 2024 was -31.70%. Twist Bioscience's PB Ratio for the quarter that ended in Mar. 2024 was 3.53. Twist Bioscience's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -8.98%.

Twist Bioscience ROE % Adjusted to Book Value Historical Data

The historical data trend for Twist Bioscience's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Twist Bioscience ROE % Adjusted to Book Value Chart

Twist Bioscience Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.42

-3.77

-12.67

-14.77

Twist Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-28.22	-20.07	-15.48	-7.75	-8.98

Competitive Comparison of Twist Bioscience's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Twist Bioscience's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Twist Bioscience's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Twist Bioscience's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Twist Bioscience's ROE % Adjusted to Book Value falls into.

Twist Bioscience ROE % Adjusted to Book Value Calculation

Twist Bioscience's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-27.76%	/	1.88
	=	-14.77%

Twist Bioscience's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-31.70%	/	3.53
	=	-8.98%

Twist Bioscience ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Twist Bioscience's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Twist Bioscience (FRA:0ME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Twist Bioscience Corp (FRA:0ME) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

TWST:USA 0ME:Germany

Address

681 Gateway Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.twistbioscience.com

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience (FRA:0ME) Headlines

No Headlines